HCA Healthcare, Inc. (NYSE:HCA) Holdings Increased by Umpqua Bank

Umpqua Bank grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,911 shares of the company’s stock after buying an additional 320 shares during the quarter. Umpqua Bank’s holdings in HCA Healthcare were worth $2,113,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HCA. FMR LLC raised its holdings in shares of HCA Healthcare by 322.3% in the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares in the last quarter. Royal London Asset Management Ltd. raised its holdings in shares of HCA Healthcare by 62.0% in the 4th quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock worth $450,461,000 after purchasing an additional 574,239 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of HCA Healthcare by 120.1% in the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock worth $262,264,000 after purchasing an additional 476,756 shares in the last quarter. Meritage Group LP bought a new stake in shares of HCA Healthcare in the 3rd quarter worth approximately $150,548,000. Finally, Raymond James Financial Inc. purchased a new position in shares of HCA Healthcare in the fourth quarter worth approximately $74,121,000. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on HCA. Truist Financial dropped their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Barclays lowered their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research report on Monday, January 27th. Bank of America decreased their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Finally, Royal Bank of Canada decreased their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Down 1.3 %

HCA opened at $329.25 on Friday. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The firm’s 50-day simple moving average is $321.50 and its 200-day simple moving average is $343.43. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The firm has a market cap of $81.06 billion, a price-to-earnings ratio of 14.99, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the company posted $5.90 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.87%. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.